VASOACTIVE PEPTIDE INHIBITION

Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin converting enzyme, and are useful in the management of diseases mediated by overproduction of, or over-responsiveness to, endothelin in mammal...

Full description

Saved in:
Bibliographic Details
Main Authors BONE, ELISABETH, ANN, WOOD, LARS, MICHAEL, CRIMMIN, MICHAEL, JOHN
Format Patent
LanguageEnglish
French
Published 14.04.1994
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin converting enzyme, and are useful in the management of diseases mediated by overproduction of, or over-responsiveness to, endothelin in mammals. Examples of such compounds are (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-L-phenylalanine; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxyethyl)-L-phenylalanine-N-methylamide; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxamido)-L-phenylalanine-N-methylamide; and (4-(N-Hydroxyamino)-2R-isopropylsuccinyl)-L-phenylalanine. Certains dérivés d'acide hydroxamique connus et leurs sels sont utiles en tant qu'inhibiteurs de la conversion de l'endothéline Big en endothéline par un enzyme de conversion de l'endothéline putatif, et le traitement de maladies dues à la surproduction d'endothéline ou à la réponse exagérée à l'endothéline chez les mammifères. Les composés utilisés peuvent être de la [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-L-phénylalanine; du [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxyéthyl)-L-phénylalanine-N-méthylamide; un [4-(N-hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxamido)-L-phénylalanine-N-méthylamide; et de la [4-(N-hydroxyamino)-2R-isopropylsuccinyl]-L-phénylalanine.
AbstractList Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin converting enzyme, and are useful in the management of diseases mediated by overproduction of, or over-responsiveness to, endothelin in mammals. Examples of such compounds are (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-L-phenylalanine; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxyethyl)-L-phenylalanine-N-methylamide; (4-(N-Hydroxyamino)-2R-isobutylsuccinyl)-4-(oxymethylenecarboxamido)-L-phenylalanine-N-methylamide; and (4-(N-Hydroxyamino)-2R-isopropylsuccinyl)-L-phenylalanine. Certains dérivés d'acide hydroxamique connus et leurs sels sont utiles en tant qu'inhibiteurs de la conversion de l'endothéline Big en endothéline par un enzyme de conversion de l'endothéline putatif, et le traitement de maladies dues à la surproduction d'endothéline ou à la réponse exagérée à l'endothéline chez les mammifères. Les composés utilisés peuvent être de la [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-L-phénylalanine; du [4-(N-Hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxyéthyl)-L-phénylalanine-N-méthylamide; un [4-(N-hydroxyamino)-2R-isobutylsuccinyl]-4-(oxyméthylènecarboxamido)-L-phénylalanine-N-méthylamide; et de la [4-(N-hydroxyamino)-2R-isopropylsuccinyl]-L-phénylalanine.
Author CRIMMIN, MICHAEL, JOHN
BONE, ELISABETH, ANN
WOOD, LARS, MICHAEL
Author_xml – fullname: BONE, ELISABETH, ANN
– fullname: WOOD, LARS, MICHAEL
– fullname: CRIMMIN, MICHAEL, JOHN
BookMark eNrjYmDJy89L5WSQDXMM9nd0DvEMc1UIcA0I8XRxVfD08_B08gzx9PfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f6WJgbmpkbmjkbGRCgBADk_Ir8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITION DES PEPTIDES VASOACTIFS
Edition 5
ExternalDocumentID WO9407527A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO9407527A23
IEDL.DBID EVB
IngestDate Fri Jul 19 11:22:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO9407527A23
Notes Application Number: WO1993GB02044
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19940414&DB=EPODOC&CC=WO&NR=9407527A2
ParticipantIDs epo_espacenet_WO9407527A2
PublicationCentury 1900
PublicationDate 19940414
PublicationDateYYYYMMDD 1994-04-14
PublicationDate_xml – month: 04
  year: 1994
  text: 19940414
  day: 14
PublicationDecade 1990
PublicationYear 1994
RelatedCompanies BRITISH BIO-TECHNOLOGY LIMITED
RelatedCompanies_xml – name: BRITISH BIO-TECHNOLOGY LIMITED
Score 2.4343688
Snippet Certain known hydroxamic acid derivatives and their salts are useful as inhibitors of the conversion of Big Endothelin to Endothelin by a putative endothelin...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title VASOACTIVE PEPTIDE INHIBITION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19940414&DB=EPODOC&locale=&CC=WO&NR=9407527A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH9ZplFvOjVOneFguBGBtWM7EDOgBEwGRBF3WyiFZJdtcRj_fV-RTS96a9rk9SN53-_3CnA_nFAudGFqo7FMM9IJ11DpcY3morJkv7S8wVfMolHwSp7mdN6B5Q4L0_QJ_WyaIyJHFcjvdSOvNz9BLK-prdw-8CVOrR_91PZU0cLFiE4MonqOzZLYi13VddFvU6NnG1csalpTlNYHaEVbkhlY5khQyua3RvFP4TBBYqv6DDrlqgfH7u7jtR4czdp8Nw5b1tuewyCbvsSy5CNjSsKSNPSYEkZB6IQyyHQBis9SN9Bwn8X-Tou3eH-i4SV00dUvr0AZC71EA6IqqVmhJcVzQ3CBBk0xKXhOraIP_T_JXP-zdgMn3z2AiWaQW-jW7x_lAJVpze-aZ_gCsKx1vg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjVWrXIw3IhAd0s5EFNeAS2PKGJvhGUh6aU2FuPfd8C2etHbZjeZfSTznm8W4HakU8ZlrkrjSZNmpDqTUOkxiea80pp-aXmLrwjCsfdCHuZ03oHFFgvT9gn9bJsjIkcVyO91K69XP0Esu62tXN-xBU693buJYYt8AxcjMlGIaJuGE0d2ZImWhX6bGD4ZuKJRVZuitN5DC1trmMFJzQaUsvqtUdwj2I-R2LI-hk657EPP2n681oeDYJPvxuGG9dYnMEynz1FT8pE6QuzEiW87gh96vuk3QaZTEFwnsTwJ98l2d8peo92JRmfQRVe_PAdhwuUSDYiqpGqFlhTLFc44GjSFXrCcasUABn-Sufhn7QZ6XhLMspkfPl7C4Xc_YCIp5Aq69ftHOUTFWrPr9km-AF_7eLE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=VASOACTIVE+PEPTIDE+INHIBITION&rft.inventor=BONE%2C+ELISABETH%2C+ANN&rft.inventor=WOOD%2C+LARS%2C+MICHAEL&rft.inventor=CRIMMIN%2C+MICHAEL%2C+JOHN&rft.date=1994-04-14&rft.externalDBID=A2&rft.externalDocID=WO9407527A2